FDA strikes cautious tone ahead of vaccine booster meeting

WASHINGTON (AP) – Influential government advisers will debate Friday if there's enough proof that a booster dose of Pfizer's COVID-19 vaccine is safe and effective – the first step toward deciding which Americans need one and when.
Source: washington times

Summary automatically generated by NewSUM A.I. from the following sources:

About the author